Back to discover
Drug

Hyaluronic Acid

In clinical development
Emerging researchLate-stage developmentSteady momentum
Also known as Amvisc, Healon, Hyaluronan, Hymovis+2 more

Amvisc, Healon, Hyaluronan, Hymovis, Orthovisc, hyaluronic acid, hydrolyzed.

9
Research papers
20
Active clinical trials
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Intraarticular Injection of Botox and Hyaluronic Acid in Knee Osteoarthritis

Clinical trial2026-06-25Results expected Q4 2026 · ClinicalTrials.gov

Does TXA Reduce Bruising After Hyaluronic Acid Filler Injection? A Prospective Half Face Study

Clinical trial2026-05-20Results expected Q4 2026 · ClinicalTrials.gov

Skin boosters: Definitions and varied classifications.

Research2024-03-01Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)

The Hyaluronan/CD44 Axis: A Double-Edged Sword in Cancer.

Research2023-10-31International journal of molecular sciences

A review of current advancements for wound healing: Biomaterial applications and medical devices.

Research2022-05-17Journal of biomedical materials research. Part B, Applied biomaterials

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Hyaluronic Acid
Aliases & brands
AmviscHealonHyaluronanHymovisOrthovischyaluronic acid, hydrolyzed
RxNorm CUI
5463
ChEMBL ID
CHEMBL5314376
ATC codes
S01KA51
UNII
S270N0TRQY

Clinical trials

142 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
142
registered trials across all phases
LATEST COMPLETION 2026
20
Active studies
17
Recruiting
101
Late-stage (III+)
82
Completed
40
Discontinued
PHASE DISTRIBUTIONn = 142
Early Phase 15Phase 16Phase 1 / 216Phase 214Phase 2 / 36Phase 318Phase 432Phase N / A45

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

9 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
20172024
Most influential

Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020 · 373 cites

Hyaluronic Acid: Redefining Its Role.

Cells · 2020 · 315 cites

A review of current advancements for wound healing: Biomaterial applications and medical devices.

Journal of biomedical materials research. Part B, Applied biomaterials · 2022 · 134 cites

Skin boosters: Definitions and varied classifications.

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024 · 43 cites
Recent papers

Skin boosters: Definitions and varied classifications.

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024 · 43 cites

The Hyaluronan/CD44 Axis: A Double-Edged Sword in Cancer.

International journal of molecular sciences · 2023 · 35 cites

A review of current advancements for wound healing: Biomaterial applications and medical devices.

Journal of biomedical materials research. Part B, Applied biomaterials · 2022 · 134 cites

Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020 · 373 cites

Hyaluronic Acid: Redefining Its Role.

Cells · 2020 · 315 cites
Major research themes8
Antineoplastic Agents1Chitosan1Cosmetic Techniques1Dermal Fillers1Drug Delivery Systems1Fibroins1Neoplasms1Platelet-Rich Plasma1
Journals, researchers & institutions
Top journals
  • Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons2
  • Biomolecules1
  • Cells1
  • International journal of molecular sciences1
  • Journal of biomedical materials research. Part B, Applied biomaterials1
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology1
Leading researchers
  • Aghaloo T2
  • Bouloux GF2
  • Chou J2
  • Giannakopoulos H2
  • Kahenasa N2
  • Krishnan D2
  • Smith JA2
  • Abatangelo G1
Leading institutions
free-text, unnormalised
  • Clinical Assistant Professor2
  • Emory University School of Medicine2
  • Oregon Health and Science University2
  • University Buffalo New York2
  • University of California-Los Angeles2
  • University of Cincinnati2

Related diseases

1 conditions

Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.

Active research areas

Related drugs

7 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Studied across 6 of the same disease areas as Hyaluronic Acid in the shared literature.

6 shared diseases1 shared paper

Studied across 5 of the same disease areas as Hyaluronic Acid in the shared literature.

5 shared diseases1 shared paper

Studied across 5 of the same disease areas as Hyaluronic Acid in the shared literature.

5 shared diseases1 shared paper

Studied across the same disease area as Hyaluronic Acid in the shared literature.

1 shared disease1 shared paper

Studied across the same disease area as Hyaluronic Acid in the shared literature.

1 shared disease1 shared paper

Frequently co-studied with Hyaluronic Acid in the research literature.

1 shared paper

Frequently co-studied with Hyaluronic Acid in the research literature.

1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials